Literature DB >> 11782762

Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation.

Martin Strüber1, Jens M Hohlfeld, Theo Kofidis, Gregor Warnecke, Jost Niedermeyer, Sebastian P Sommer, Axel Haverich.   

Abstract

OBJECTIVE: Surfactant function was shown to be impaired in clinical and experimental lung transplantation. This study was designed to define the impact of retrograde flush perfusion on graft and surfactant function after an extended period of ischemia.
METHODS: Left lung transplantation was performed after 24 hours of graft ischemia in 12 pigs. In half of the grafts antegrade cold flush perfusion (Perfadex) was used for preservation. In the second group grafts were flushed in a retrograde fashion via the left atrium. Graft function was monitored for 7 hours after transplantation. Before transplantation (basal) and after 2 hours of reperfusion, bronchoalveolar lavage fluid was obtained. Minimal surface tension of bronchoalveolar lavage fluid was determined and the ratio of small and large surfactant aggregates was calculated. Lung water content was analyzed online in the reperfusion period.
RESULTS: Right-sided heart failure developed in 2 animals of group 1 (antegrade perfusion) within 2 and 4.5 hours of reperfusion, respectively. All other pigs survived the observation period. PO(2)/FIO(2) (P =.001) and dynamic lung compliance (P =.001) were superior in retrogradely flushed grafts. A comparable increase of minimal surface tension was found after reperfusion in both groups. Small/large surfactant aggregate ratio after reperfusion (P =.03), as well as extravascular lung water content, was higher in the antegrade perfusion group.
CONCLUSION: Retrograde flush perfusion for 24-hour lung preservation with low-potassium dextran (Perfadex) solution led to better initial graft function than the standard antegrade perfusion technique. A moderate impairment of surfactant function was found in both groups, which was more pronounced in the antegrade perfusion group.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782762     DOI: 10.1067/mtc.2002.119063

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  Preservation solution for lung transplantation.

Authors:  Yoshinori Okada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-12

2.  Stereological assessment of the blood-air barrier and the surfactant system after mesenchymal stem cell pretreatment in a porcine non-heart-beating donor model for lung transplantation.

Authors:  Anke Schnapper; Astrid Christmann; Lars Knudsen; Parwis Rahmanian; Yeong-Hoon Choi; Mohamed Zeriouh; Samira Karavidic; Klaus Neef; Anja Sterner-Kock; Maria Guschlbauer; Florian Hofmaier; Alexandra C Maul; Thorsten Wittwer; Thorsten Wahlers; Christian Mühlfeld; Matthias Ochs
Journal:  J Anat       Date:  2017-11-28       Impact factor: 2.610

Review 3.  Review of donor and recipient surgical procedures in lung transplantation.

Authors:  Duy C Nguyen; Gabriel Loor; Philip Carrott; Alexis Shafii
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  Improvement of surgical techniques for orthotopic single lung transplantation in rats.

Authors:  Peigen Gao; Chongwu Li; Ye Ning; Junqi Wu; Pei Zhang; Xiucheng Liu; Yiliang Su; Deping Zhao; Chang Chen
Journal:  Ann Transl Med       Date:  2022-06

5.  Lung transplantation for cystic fibrosis.

Authors:  Frederick R Adler; Paul Aurora; David H Barker; Mark L Barr; Laura S Blackwell; Otto H Bosma; Samuel Brown; D R Cox; Judy L Jensen; Geoffrey Kurland; George D Nossent; Alexandra L Quittner; Walter M Robinson; Sandy L Romero; Helen Spencer; Stuart C Sweet; Wim van der Bij; J Vermeulen; Erik A M Verschuuren; Elianne J L E Vrijlandt; William Walsh; Marlyn S Woo; Theodore G Liou
Journal:  Proc Am Thorac Soc       Date:  2009-12

6.  National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation.

Authors:  Michael S Mulligan; David Weill; R Duane Davis; Jason D Christie; Farhood Farjah; Jonathan P Singer; Matthew Hartwig; Pablo G Sanchez; Daniel Kreisel; Lorraine B Ware; Christian Bermudez; Ramsey R Hachem; Michael J Weyant; Cynthia Gries; Jeremiah W Awori Hayanga; Bartley P Griffith; Laurie D Snyder; Jonah Odim; J Matthew Craig; Neil R Aggarwal; Lora A Reineck
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08-18       Impact factor: 5.209

7.  Splenocyte Infusion and Whole-Body Irradiation for Induction of Peripheral Tolerance in Porcine Lung Transplantation: Modifications of the Preconditioning Regime for Improved Clinical Feasibility.

Authors:  Katharina Jansson; Karla Dreckmann; Wiebke Sommer; Murat Avsar; Jawad Salman; Thierry Siemeni; Ann-Kathrin Knöfel; Linda Pauksch; Jens Gottlieb; Jörg Frühauf; Martin Werner; Danny Jonigk; Martin Strüber; Axel Haverich; Gregor Warnecke
Journal:  Transplant Direct       Date:  2017-06-06

8.  What is the role of surfactant and inhaled nitric oxide in lung transplantation?

Authors:  Martin Strüber
Journal:  Crit Care       Date:  2002-05-09       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.